BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

VistaGen Therapeutics, Inc. 

384 Oyster Point Boulevard
Suite 8
South San Francisco  California  94080  U.S.A.
Phone: 650-244-9990 Fax: 650-244-9979


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





 Company News
VistaGen Therapeutics, Inc. Receives Notice Of Allowance For U.S. Patent Expanding Stem Cell Technology Platform For Drug Rescue And Regenerative Medicine 4/23/2014 8:54:51 AM    More...
VistaGen Therapeutics, Inc. Joins The Cardiac Safety Research Consortium 4/11/2014 10:15:35 AM    More...
Autilion AG Invests $36 Million Into VistaGen Therapeutics, Inc. 6/28/2013 11:26:22 AM    More...
VistaGen Therapeutics, Inc. Presents CardioSafe 3D™ and LiverSafe 3D™ Developments at International Society for Stem Cell Research's 11th Annual Meeting 6/18/2013 9:03:17 AM    More...
VistaGen Therapeutics, Inc. and Duke University Publish Results on Production of Functional 3D Human Heart Tissue 5/7/2013 10:32:15 AM    More...
VistaGen Therapeutics, Inc. Raises $36 Million 4/10/2013 7:21:28 AM    More...
VistaGen Therapeutics, Inc. to Present Enhancements and Expanded Validation of LiverSafe 3D™ at Society of Toxicology's 52nd Annual Meeting 3/12/2013 9:09:33 AM    More...
VistaGen Therapeutics, Inc. to Present CardioSafe 3D™ Developments at Society of Toxicology's 52nd Annual Meeting 3/11/2013 9:57:36 AM    More...
VistaGen Therapeutics, Inc. Enters Strategic Collaboration With Celsis In Vitro Technologies (CEL.L) to Further Advance LiverSafe 3D™ 3/4/2013 9:44:26 AM    More...
VistaGen Therapeutics, Inc.'s Collaborators Identify Definitive Precursor for Adult Blood and the Immune System 2/7/2013 9:20:42 AM    More...
1234567

//-->